請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/9564
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 吳淑瓊(Shwu-Chong Wu) | |
dc.contributor.author | Chia-Wei Wang | en |
dc.contributor.author | 王嘉薇 | zh_TW |
dc.date.accessioned | 2021-05-20T20:28:54Z | - |
dc.date.available | 2008-12-29 | |
dc.date.available | 2021-05-20T20:28:54Z | - |
dc.date.copyright | 2008-09-11 | |
dc.date.issued | 2008 | |
dc.date.submitted | 2008-08-01 | |
dc.identifier.citation | 中文部分:
內政部(2008)。內政部統計年報。線上檢索日期2008年4月1日。 網址:http://www.moi.gov.tw/stat/index.asp 經建會(2006)。中華民國臺灣95年至140年人口推計。台北市:經建會 蔣秀容、徐畢卿:認識老人憂鬱症—精神科臨床住院老人之分析報告。榮總護理,2002,卷19期4,頁371-378。 林怡君、余豎文、張宏哲:新店地區機構和非機構老人憂鬱情形及相關因素之調查。臺灣家庭醫學誌,2004,卷14期2,頁81-93。 林志強、夏一新、陸汝斌:老人憂鬱症。李明濱編,精神醫學新知。台北:臺灣醫學會,1999,頁79-92。 呂淑妤、林宗義:南區社區老人憂鬱症狀盛行率及相關因素研究。中華衛誌,2000,卷19期1,頁50-60。 邵靖翰:玉里地區老人憂鬱盛行率及危險因子之探討。國立陽明大學公共衛生研究所流行病學組碩士論文,2004。 江弘基、戴傳文、李明濱、王銘光、張文穎、蔡佩樺:老人自殺問題。臺灣醫學,2006,卷10期3,頁353-361。 楊明仁:臺灣的社會與憂鬱。學生輔導,2002,期80,頁52-59。 葉雅馨、林家興:臺灣民眾憂鬱程度與求助行為的調查研究。中華心理衛生學刊,2006,卷19期2,頁125-148。 鄭惠信、史麗珠、謝瀛華、盧成皆:老年人憂鬱因子之相關研究。內科學誌,1995,卷六期2,頁125-134。 臨床心理師公會(2008)。臨床心理師人力調查。線上檢索日期2008年7月27日。 http://www.atcp.org.tw/news_ok.php?nid=99 陳豐偉、施紅圭、李昱、楊明仁:憂鬱症病人重複住院之影響因素。臺灣精神醫學,卷16期2,頁43-49。 台北市政府衛生局(2003)。憂鬱症照護網認證。「臺北市憂鬱症共同照護網」憂鬱症共同照護指引。線上檢索日期96年12月2日。 網址:www.health.gov.tw/Portals/0/醫護管理處/blue_1.doc 許桂森、林明忠、蕭哲志(譯) (2004):簡明圖解藥理學。台北市:藝軒。(Harvey, R. A., & Champe, P. C.) 趙建剛:老年憂鬱症之治療與處理。臨床醫學,2003,卷52期3,頁197-202。 周玉慧、莊義利:晚年生活壓力、社會支持與老人身心健康之變遷:長期資料分析。人文及社會科學集刊,2000,卷12期2,頁281-317。 黃繼慶:社會支持系統對社區老人心理健康的影響。國立臺灣大學公共衛生研究所碩士論文,1994。 全民健康保險(2007)。藥品給付規定。線上檢索日期97年7月14日。 網址:http://www.nhi.gov.tw/webdata/webdata.asp?menu=3&menu_id=56& webdata_id=1119 賴德仁(2008)。臺灣憂鬱症防治協會。線上檢索日期97年5月30日。 網址:http://www.depression.org.tw/about/capter.asp 內政部(2002)。中華民國台閩地區老人狀況調查報告。台北市:內政部統計處。 吳淑瓊、莊坤洋:在地老化:台灣二十一世紀長期照護的政策方向。台灣衛誌,2001,卷20期3,頁192-201。 英文部分: Abas, M., Hotopf, M., & Prince, M. (2002). Depression and mortality in a high-risk population 11-Year follow-up of the Medical Research Council Elderly Hypertension Trial. British Journal of Psychiatry, 181, 123-128. Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., & Bryson, H., et al. (2004a). Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand, 109(Suppl 420), 21–27. Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., & Bryson, H., et al. (2004b). Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand, 109(Suppl 420), 47-54. Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., & Bryson, H., et al. (2004c).Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand, 109(Suppl 420), 55-64. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders : DSM-IV-TR. (4th ed., text revision). Washington, DC: Author. Barbui, C., Broglio, E., Laia, A. C., D’Agostino, S., Enrico, F., & Ferraro, L., et al. (2003). Cross-sectional database analysis of antidepressant prescribing in Italy. Journal of Clinical Psychopharmacology, 23(1), 31-34. Bauer, M., Bschor, T., Pfennig, A., Whybrow, P.C., Angst, J., & Versiani, M., et al. (2007). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World Journal of Biological Psychiatry, 8(2), 67-104. Beck, C. A., & Patten, S. B. (2004). Adjustment to Antidepressant Utilization Rates to Account for Depression in Remission. Comprehensive Psychiatry, 45(4), 268-274. Beck, C. A., Patten, S. B., Williams, J. V. A., Wang, J. L., Currie, S. R., & Maxwell, C. J., et al. (2005). Antidepressant utilization in Canada. Social Psychiatry and Psychiatric Epidemiology, 40, 799–807. Beekman, A. T. F., Deeg, D. J. H., VanLimbeek, J., Braam, A. W., DeVries, M. Z., & VanTilburg, W. (1997). Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): Results from a community-based sample of older subjects in the Netherlands. Psychological Medicine, 27(1), 231-235. Beekman, A. T. F., Copeland, J. R. M., & Prince, M. J. (1999). Review of community prevalence of depression in later life. British Journal of Psychiatry, 174, 307-311. Blazer, D. G. (2003). Depression in Late Life: Review and Commentary. Journal of Gerontology, 58A(3), 249–265. Blazer, D. G., Hybels, C. F., Fillenbaum, G. G., & Pieper, C. F. (2005). Predictors of antidepressant use among older adults: Have they changed over time? American Journal of Psychiatry, 162(4), 705-710. Bramesfeld, A., Grobe, T., & Schwartz, F. W. (2007). Who is treated, and how, for depression? An analysis of statutory health insurance data in Germany. Social Psychiatry and Psychiatric Epidemiology, 42(9), 740-746. Brown, S. L., Salive, M. E., Guralnik, J. M., Pahor, M., Chapman, D. P., & Blazer, L. D. (1995). Antidepressant use in the elderly- Association with demographic characteristics, health-related factors, and health-care utilization. Journal of clinical epidemiology, 48(3), 445-453. Burt, V. K., Stein, K. (2002). Epidemiology of depression throughout the female life cycle. Journal of Clinical Psychiatry, 63, 9-15. Callahan, C. M., Hui, S. L., Nienaber, N. A., Musick, B. S., & Tierney, W. M. (1999). Longitudinal study of depression and health-services use among elderly primary-care patients. Journal of the American Geriatrics Society, 42(8), 833-838. Cheng, S. T., & Chan, C.M. (2005). The Center for Epidemiologic Studies Depression Scale in older Chinese: thresholds for long and short forms. International Journal of Geriatric Psychiatry, 20, 465–470. Chien, I. C., Bih, S. H., Chou, Y. J., Lin, C. H., Lee, W. G., & Chou, P. (2007). Trends in the use of psychotropic drugs in Taiwan: A population-based National Health Insurance study, 1997–2004. Psychiatric Services, 58, 554-557. Cole, M. G., & Bellavance, F. (1997). Depression in elderly medical inpatients: a meta-analysis of outcomes. Canadian Medical Association Journal, 157(8): 1055-1060. Cole, M. G., Bellavance, F., & Mansour, A. (1999). Prognosis of depression in elderly community and primary care populations: a systematic review and meta-analysis. American Journal of Psychiatry, 156(8), 1182-1189. Collin, C., Wade, D. T., Davies, S., & Horne, V. (1988). The Barthel ADL Index: a reliability study. International Disability Studies, 10, 61-63. Crystal, S., Sambamoorthi, U., Walkup, J. T., & Akincigil, A. (2003). Diagnosis and treatment of depression in the elderly Medicare population: Predictors, disparities, and trends. Journal of the American Geriatrics Society, 51, 1718-1728. Davidson, H., Feldman, P. H., & Crawford, S. (1994). Measuring depressive symptoms in the frail elderly. Journal of Gerontology, 49, 159-164. Fick, D. M., Cooper, J. W., Wade, W. E., Waller, J. L., Maclean, J. R., & Beers, M. H., et al. (2003). Updating the beers criteria for potentially inappropriate medication use in older adults-Results of a US consensus panel of experts. Archives of Internal Medicine, 163, 2716-2724. Fillenbaum, G. G., Hybels, C. F., Pieper, C. F., Konrad, T. R., Burchett, B. M., & Blazer, D. G. (2006). Provider characteristics related to antidepressant use in older people. Journal of the American Geriatrics Society, 54(6), 942-949. Fischer, L. R., Wei, F. F., Rolnick, S. J., Jackson, J. M., Rush, W. A., & Garrard, J. M., et al. (2002). Geriatric depression, antidepressant treatment, and healthcare utilization in a health maintenance organization. Journal of the American Geriatrics Society, 50(2), 307-312. Flint, A. J. (1998). Choosing appropriate antidepressant therapy in the elderly - A risk-benefit assessment of available agents. Drugs & Aging, 13 (4), 269-280. Gardarsdottir, H., Heerdink, E. R., Dijk, L., & Egberts, A. C. G. (2007). Indications for antidepressant drug prescribing in general practice in the Netherlands. Journal of Affective Disorders, 98, 109-115. Grunebaum, M. F., Oquendo, M. A., & Manly, J. J. (2008). Depressive symptoms and antidepressant use in a random community sample of ethnically diverse, urban elder persons. Journal of Affective Disorders, 105, 273-277. Gum, A. M., Arean, P. A., Hunkeler, E., Tang, L. Q., Katon, W., & Hitchcock, P., et al. (2006). Depression treatment preferences in older primary care patients. Gerontologist , 46(1), 14-22. Guralnik, J. M., & Simonsick, E. M. (1993). Physical disability in older Americans. Journal of Gerontology, 48(suppl), 3-10. Haringsma, R., Engels, G. I., Beekman, A. T. F., & Spinhoven, Ph. (2004). The criterion validity of the Center for Epidemiological Studies Depression Scale (CES-D) in a sample of self-referred elders with depressive symptomatology. International Journal of Geriatric Psychiatry, 19, 558-563. Himmelfarb, S., & Murrell, S. A. (1983). Reliability and validity of five mental health scales in older persons. Journal of Gerontology, 38, 333-339. Hirschfeld, R. M., Keller, M. B., Panico, S., Arons, B. S., Barlow, D., & Davidoff, F., et al. (1997). The national depressive and manic-depressive association consensus statement on the undertreatment of depression. JAMA, 277, 333-340. Holden, C. (2000). Global survey examines impact of depression. A new WHO study seeks to verify recent findings on the social and economic burden of depression worldwide using standardized instruments. Science, 288, 39-40. Hooyman, N., & Kiyak, A. (2002). Personality and mental health in old age, Social Gerontology: A Multidisciplinary Perspective (pp.194). Boston : Allyn and Bacon. Hsieh, M. H., Lai, T. J. (2005). Depression in late life: Current issues. Taiwanese Journal of Psychiatry, 19, 85-99. IMS Health (2006). Leading Therapy Classes by Global Pharmaceutical Sales, 2006. Retrieved Nov 10, 2007 from the World Wide Web: http://www.imshealth.com/ims/portal/front/articleC/0,2777,6319_80528184_80530441,00.html Katz, S., Ford, A. B., Moskowitq, R. W., Jackson, B. A., & Jaffe, M. W. (1963). Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA, 185, 914-919. Keller, M. B., Harrison, W., Fawcett, J. A., Gelenberg, A., Hirschfeld, R. M., & Klein, D., et al. (1995). Treatment of chronic depression with sertraline and imipramine: preliminary blinded response rates and high rates of undertreatment in the community. Psychopharmacology Bulletin, 31, 205–212. Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., & Merikangas, K. R., et al. (2003). The epidemiology of major depressive disorder - Results from the National Comorbidity Survey Replication (NCS-R). JAMA, 289, 3095-3105. Kohn, R., Saxena, S., Levav, I., & Saraceno, B. (2004). The treatment gap in mental health care. Bulletin of the World Health Organization, 82, 858-866. Kohout, F. J., Berkman, L. F., Evans, D. A., & Cornoni-Huntley, J. (1993). Two shorter forms of the CES-D Depression Symptoms Index. Journal of Aging and Health, 5, 179-193. Kvela, S. L., & Pahkala, K. (2001). Depressive disorder as a predictor of physical disability in old age. Journal of the American Geriatric Society, 49(3), 290-296. Laukkala, T., Isometsä, E., Hämäläinen, J., Heikkinen, M., Lindeman, S., & Aro, H. (2001). Antidepressant treatment of depression in the Finnish general population. American Journal of Psychiatry, 158, 2077–2079. Lawrenson, R. A., Tyrer, F., Newson, R. B., & Farmer, R. D. T. (2000). The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. Journal of Affective Disorders, 59(2), 149-157. Lawton, M. P., & Brody, E. M. (1969). Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist, 9, 179-186. Lewinsohn, P. M., Seeley, J. R., Roberts, R. E., & Allen, N. B. (1997). Center for Epidemiologic Studies Depression Scale (CES-D) As a screening instrument for depression among community-residing older adults. Psychology and Aging, 12(2), 277-287. Lin, L. C., Wang, T. G., Chen, M. Y., Wu, S. C., & Portwood, M. J. (2005). Depressive symptoms in long-term care residents in Taiwan. Journal of Advanced Nursing, 51(1), 30-37. Liu, C. Y., Wang, S. J., Teng, E. L., Fuh, J. L., Lin, C. C., & Lin, K. N., et al. (1997). Depressive disorders among older residents in a Chinese rural community. Psychological Medicine, 27(4), 943-949. Lyness, J. M., Noel, T. K., Cox, C., King, D. A., Conwell, Y., & Caine ED. (1997). Screening for depression in elderly primary care patients - A comparison of the center for epidemiologic studies depression scale and the geriatric depression scale. Archives of Internal Medicine, 157(4), 449-454. Lyness, J. M., King, D. A., Cox, C., Yoediono, Z., & Caine, E. D. (1999). The importance of subsyndromal depression in older primary care patients: prevalence and associated functional disability. Journal of the American Geriatric Society, 47, 647-652. Mamdani, M., Parikh, S. V., Austin, P. C., & Upshur, R. E. G. (2000). Use of antidepressants among elderly subjects: Trends and contributing factors. American Journal of Psychiatry, 157, 360–367. McCracken, C., Dalgard, O. S., Ayuso-Mateos, J. L., Casey, P., Wilkinson, G., & Lehtinen, V., et al. (2006). Health service use by adults with depression: community survey in five European countries - Evidence from the ODIN study. British Journal of Psychiatry, 189, 161-167. McGrady, A., Lynch, D., Nagel, R., & Wahl E. (2003). Application of the high risk model of threat perception to medical illness and service utilization in a family practice. Journal of Nervous and Mental Disorders, 191, 255-259. McManus, P., Mant, A., Mitchell, P. B., Montgomery, W. S., Marley, J., & Auland, M. E. (2000). Recent trends in the use of antidepressant drugs in Australia, 1990-1998. Medical Journal of Australia, 173(9), 458-461. Mehta, K. M., Yaffe, K., & Covinsky, K. E. (2002). Cognitive impairment, depressive symptoms and functional decline in older people. Journal of the American Geriatric Society, 50(6), 1045-1050. Micromedex. (2008). Retrived 4 Mar, 2008 from the World Wide Web: http://library2.mc.ntu.edu.tw/hcs/librarian/PFPUI/NXakUT2xvgKja Moller-Leimkuhler, A.M., (2002). Barriers to help-seeking by men: a review of sociocultural and clinical literaturewith particular reference to depression. Journal of Affective Disorders, 71, 1-9. Montagnier, D., Barberger-Gateau, P., Jacqmin-Gadda, H., Dartigues, J. F., Rainfray, M., & Peres, K., et al. (2006). Evolution of prevalence of depressive symptoms and antidepressant use between 1988 and 1999 in a large sample of older French people: Results from the Personnes Agees Quid Study. Journal of the American Geriatrics Society, 54(12), 1839-1845. Murray C. J. L., Lopez A. D. (1997). Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet, 349, 1436-1442. Nemeroff, C. B. (1994). Evolutionary trends in the pharmacotherapeutic management of depression. Journal of Clinical Psychiatry, 55(12), 3-15. Newman, S. C., & Hassan, A. I. (1999). Antidepressant use in the elderly population in Canada: Results from a national survey. Journals of Gerontology Series A-Biologigal Sciences and Medical Sciences, 54(10), 527-530. Old Age Depression Interest Group. (1993). How long should theelderly take antidepressants? A double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry, 162, 175-182. Osborn, D. P., Fletcher, A. E., Smeeth, L., Stirling, S., Nunes, M., & Breeze, E., et al. (2002). Geriatric Depression Scale Scores in a representative sample of 14 545 people aged 75 and over in the United Kingdom: results from the MRC Trial of assessment and management of older people in the community. International Journal of Geriatric Psychiatry, 17(4), 375-382. Parikh, S. V., Lin, E., Lesage, A. D: (1997). Mental health treatment in Ontario: selected comparisons between the primary care and specialty sectors. Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie, 42, 929–934. Patten, S. B. (2004). Major depression and mental health care utilization in Canada: 1994 to 2000. Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie, 49(5), 303-309. Patten, S. B., Esposito, E., & Carter, B. (2007). Reasons for antidepressant prescriptions in Canada. Pharmacoepidemiology and drug safety, 16(7), 746–752. Paulose-Ram R., Safran, M. A., Jonas, B. S., Gu, Q. P., & Orwig, D. (2007). Trends in psychotropic medication use among US adults. Pharmacoepidemiology and drug safety, 16(5), 560-570. Penninx, B. W. J. H., Guralnik, J. M., Ferrucci, L., Simonsick, E. M., Deeg, D. J. H., & Wallace, R. B. (1998). Depressive symptoms and physical decline in community-dwelling older persons. JAMA, 279, 1720-1726. Percudani, M., Barbui, C., Fortino, I., & Petrovich, L. (2004). Antidepressant drug use in Lombardy, Italy: a population-based study. Journal of Affective Disorders, 83, 169–175. Percudani, M., Barbui, C., Fortino, I., & Petrovich, L. (2005). Antidepressant drug prescribing among elderly subjects: a population-based study. International Journal of Geriatric Psychiatry, 20, 113–118. Petrovic, M., De Paepe, P., & Van Bortel, L. (2005). Pharmacotherapy of depression in old age. Acta Clinica Belgica, 60(3), 150-156. Pfeiffer, E. (1975). A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. Journal of the American Geriatrics Society, 23(10), 433-441. Pietraru, C., Barbui, C., Poggio, L., & Tognoni, G. (2001). Antidepressant drug prescribing in Italy, 2000: analysis of a general practice database. European Journal of Clinical Pharmacology, 57, 605-609. Pinquart, M., Duberstein, P. R., Lyness, J. M. (2006). Treatments for later-life depressive conditions: A meta-analytic comparison of pharmacotherapy and psychotherapy. American Journal of Psychiatry, 163, 1493-1501. Pollock, B. G., Mulsant, B. H., Nebes, R., Kirshner, M. A., Begley, A. E., & Mazumdar, S., et al. (1998). Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline. American Journal of Psychiatry, 155(8), 1110-1112. Preskorn S. H. (1993). Recent Pharmacological Advances in antidepressant therapy for the elderly. American Journal of Medicine, 9 (Suppl. 5A), S2-S12. Radloff, L. S. (1977). The CES-D Scale: A Self-Report Depression Scale for Research in the General Population. Applied Psychological Measurement, 1, 385-401. Raymond, C. B., Morgan, S. G., & Caetano, P. A. (2007). Antidepressant Utilization in British Columbia From 1996 to 2004: Increasing Prevalence but Not Incidence. Psychiaric Services, 58(1), 79-84. Reynolds, C. F., Frank, E., Kupfer, D. J., Thase, M. E., Perel, J. M., & Mazumdar, S., et al. (1996). Treatment outcome in recurrent major depression: a post hoc comparison of elderly (‘‘young old’’) and midlife patients. American Journal of Psychiatry, 153(10), 1288-1292. Roose, S. P., Laghrissi-Thode, F., Kennedy, J. S., Nelson, J. C., Bigger, J. T., & Pollock, B. G., et al. (1998). Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA, 279, 287-291. Shrout P. E., & Yager T. J. (1989). Reliability and validity of screening scales: effect of reducing scale length. Journal of Clinical Epidemiology, 42; 69-78. Simon, G. E., Fleck, M., Lucas, R., & Bushnell, D. M. (2004). Prevalence and predictors of depression treatment in an international primary care study. American Journal of Psychiatry, 161(9), 1626-1634. Smith, G. C. (2003). Patterns and predictors of service use and unmet needs among aging families of adultswith servere mental illness. Psychiatric Services, 54, 871-877. Sonnenberg, C. M., Beekman, A. T. F, Deeg, D. J. H., & Willem, T. (2003). Drug treatment in depressed elderly in the Dutch community. International Journal of Geriatric Psychiatry, 18, 99–104. Soudry, A., Dufouil, C., Ritchie, K., Dartigues, J. F., Tzourio, C., & Alperovitch, A. (2008). Factors associated with antidepressant use in depressed and non-depressed community-dwelling elderly: the three-city study. International Journal of Geriatric Psychiatry, 23, 324-330. Statistics Canada. (2003). Canadian Community Health Survey: Mental Health and Well-being. Retrieved Mar 5, 2008 from the World Wide Web: http://www.statcan.ca/english/freepub/82-617-XIE/index.htm Steffens, D. C., Skoog, I., Norton, M. C., Hart, A. D., Tschanz, J. T., & Plassman, B. L., et al. (2000). Prevalence of depression and its treatment in an elderly population - The Cache County study. Archives of General Psychiatry, 57, 601-607. Sørgaard, K. (1999). Studies in Psychiatric Help-seeking. Oslo: Institute Group of Psychiatry,University of Oslo. Tannock, C., Katona, C. (1995). Minor depression in the aged- Concepts, Prevalence and Optimal management. Drugs and Aging, 6, 278-292. Ten, H.,Vollebergh, W., Bijl, R., et al. (2002). Combined effect of mental disorder and low social support on care service use formental health problems in the Dutch general population. Psychological Medicine, 32, 311-323. The WHO World Mental Health Survey Consortium. (2004). Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA , 291, 2581-2590. Ubeda, A., Cardo, E., Selles, N., Broseta, R., Trillo, J. L., & Fernandez-Llimos, F. (2007). Antidepressant utilization in primary care in a Spanish region - Impact of generic and reference-based pricing policy (2000-2004). Social Psychiatry and Psychiatric Epidemiology, 42(3), 181-188. Uchida, N., Chong, M. Y., Tan, C. H., Nagai, H., Tanaka, M., & Lee, M. S., et al. (2007). International study on antidepressant prescription pattern at 20 teaching hospitals and major psychiatric institutions in East Asia: Analysis of 1898 cases from China, Japan, Korea, Singapore and Taiwan. Psychiatry and Clinical Neurosciences, 61, 522–528. Ufer, M., Meyer, S. A., Selke, O. J., Volz, H. P., Hedderich, J., & Gleiter, C. H. (2007). Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis. Pharmacoepidemiology and drug safety, 16, 1153–1160. Unutzer, J., Katon, W., Callahan, C. M., Williams, J. W., Hunkeler, E., & Harpole, L., et al. (2003). Depression treatment in a sample of 1,801 depressed older adults in primary care. Journal of the American Geriatrics Society, 51(4), 505-514. Wada, T., Ishine, M., Sakagami, T., Okumiya, K., Fujisawa, M., & Murakami, S., et al. (2004). Depression in Japanese community-dwelling elderly - prevalence and association with ADL and QOL. Archives of Gerontology and Geriatrics, 39(1), 15-23. Washington University School of Medicine (2008). History and scope. Washington, DC: Author. Retrieved June 5, 2008 from the World Wide Web: http://epi.wustl.edu/DIS/disdescription.htm#HISTORY%20AND%20SCOPE Wei, W. H., Sambamoorthi, U., Olfson, M., Walkup, J. T., Crystal, S. (2005). Use of psychotherapy for depression in older adults. American Journal of Psychiatry, 162, 711-717. Wittchen, H. U., Pittrow, D. (2002). Prevalence, recognition and management of depression in primary care in Germany: the Depression 2000 study. Human Psychopharmacology-Clinical and Experimental, 17(Suppl 1), 1-11. World Health Organization. (2001a). Global Burden of Disease (GBD) 2001 Estimates. Geneva: Author. Retrieved Apr 1, 2008 from the World Wide Web: http://www.who.int/healthinfo/statistics/bodgbd2001/en/index.html World Health Organization. (2001b). The world health report 2001: mental health : new understanding, new hope(pp.11, pp.30). Geneva: Author. World Health Organization (2004). About the WHO CIDI. Geneva: Author. Retrieved June 5, 2008 from the World Wide Web: http://www.hcp.med.harvard.edu/wmhcidi/about.php Wu, S. C., Ke, D., Su, T. L. (1998). The prevalence of cognitive impairment among nursing home residents in Taipei, Taiwan. Neuroepidemiology, 17, 147-153. Wulsin, L. R., & Singal, B.M. (2003). Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosomatic Medicine, 65(2), 201-210. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/9564 | - |
dc.description.abstract | 本研究目的為瞭解臺灣失能老人的重鬱症傾向分佈情形與抗憂鬱藥物使用情形,包括年使用盛行率、抗憂鬱藥物治療率、處方藥品及類別、處方科別及疾病診斷。並探討人口學背景、健康與照顧狀況及社會支持系統與重鬱症傾向者使用抗憂鬱藥物的相關情況。
研究樣本來自「全國長期照護需要評估」計畫資料中65歲以上的失能樣本,共12,030人,另以調查檔的CES-D問卷篩選出CES-D≧25分的重鬱症傾向樣本,共1,015人。由調查檔中得到樣本之性別、年齡、教育程度、籍貫、重鬱症傾向、身體功能狀況、照顧安排、社會網絡與社會支持等資訊,再連結全民健康保險資料檔,以取得個案在訪視後一年期間的抗憂鬱藥物處方及診斷資訊,進而分析整體失能老人以及重鬱症傾向失能老人的抗憂鬱藥物使用情形。 結果發現臺灣失能老人CES-D總分的平均值為13.3分,有重鬱症傾向者占12.6% (CES-D≧25分)。在雙變項分析中可發現女性、65-74歲(年輕老人)、未受正式教育、免部份負擔、居住在直轄市、有認知障礙、完全依賴、四種以上慢性疾病、居住在機構、低社會網絡、低情緒性支持、低工具性支持者有重鬱症傾向的比率較高。 臺灣失能老人抗憂鬱藥物年使用盛行率為12.5% (1,499人),年抗憂鬱藥物處方數為10,276張,僅有31.6%用於治療憂鬱症。有重鬱症傾向者,在訪視後一年有使用抗憂鬱藥物者占17.5%;而有重鬱症傾向者,且在訪視後一年有使用抗憂鬱藥物治療憂鬱症者,僅占5.9%。總和門診和住院的抗憂鬱藥物處方(10,276張)來說,處方數目最多的是TCA類,占39.0%,接下來是Heterocyclic類,占27.3%,第三名則是SSRI類,占21.8%,最後則是MAOI類,占11.9%。而用於治療憂鬱症的抗憂鬱藥物處方中(3,244張),第一名是SSRI類,占42.8%,接下來是Heterocyclic類,占29.8%,第三名則是TCA類,占16.8%,最後則是MAOI類,占10.6%。在雙變項分析中,藥物類別和處方診斷有顯著相關,SSRI類(62.0%)最常用以治療憂鬱症,TCA類(74.1%)、MAOI類(61.2%)及Heterocyclic類(40.0%)都最常用以治療其他疾病。不同科別的醫師常用的抗憂鬱藥物類別亦不相同,精神科醫師主要處方SSRI類,而復健科及放射線科最常處方Heterocyclic類,其他如神經科、內科、家醫科、不分科、泌尿科、骨科、神經外科及皮膚科等都最常處方TCA類。 複邏輯斯迴歸分析發現,年齡、部分負擔、照顧安排、固定就醫傾向和重鬱症傾向者是否使用抗憂鬱藥物有顯著相關。相較於85歲以上者,65-74歲(OR=2.342, 95%CI=1.173-4.674)及75-84歲(OR=2.113, 95%CI=1.089-4.099)的重鬱症傾向者使用抗憂鬱藥物的機會較高。相較於需部分負擔者,免部分負擔(OR=1.636, 95%CI=1.090-2.456)的重鬱症傾向者使用抗憂鬱藥物的機會較高。相較於居家無照顧者,有居家家庭照顧者(OR=1.482, 95%CI=0.876-2.506)或居家全職看護(OR=2.572, 95%CI=1.260-5.248)的重鬱症傾向者使用抗憂鬱藥物的機會較高。相較於固定就醫傾向者,不固定就醫(OR=3.696, 95%CI=2.191-6.236)及中度就醫傾向(OR=1.555, 95%CI=0.844-2.863)的重鬱症傾向者使用抗憂鬱藥物的機會較高。 在重鬱症傾向者使用抗憂鬱藥物治療憂鬱症的影響因素方面,複邏輯斯迴歸分析發現,部分負擔、城鄉別、照顧安排、固定就醫傾向都和重鬱症傾向者是否使用抗憂鬱藥物治療憂鬱症有顯著相關。相較於需部分負擔者,免部分負擔(OR=2.211, 95%CI=1.167-4.189)的重鬱症傾向者使用抗憂鬱藥物治療憂鬱症的機會較高。相較於居住在鄉鎮區者,居住在直轄市(OR=3.276, 95%CI=1.443-7.435)、省轄市(OR=1.496, 95%CI=0.640-3.500)、縣轄市(OR=1.178, 95%CI=0.491-2.823)的重鬱症傾向者使用抗憂鬱藥物治療憂鬱症的機會較高。相較於居家無照顧者,有居家家庭照顧者(OR=1.175, 95%CI=0.496-2.782)或居家全職看護(OR=3.250, 95%CI=1.102-9.583)的重鬱症傾向者使用抗憂鬱藥物治療憂鬱症的機會較高。相較於固定就醫傾向者,不固定就醫(OR=3.069, 95%CI=1.276-7.383)及中度就醫傾向(OR=1.189, 95%CI=0.404-3.498)的重鬱症傾向者使用抗憂鬱藥物治療憂鬱症的機會較高。 憂鬱是失能老人相當常見的問題,而失能老人有重鬱症傾向者在未來一年使用抗憂鬱藥物的比例相當低,而使用抗憂鬱藥物是用以治療憂鬱症的比例更低。藉由對失能老人重鬱症傾向者使用抗憂鬱藥物治療憂鬱症的相關分析發現,居住在鄉鎮區、居家無照顧者、需要部分負擔、固定就醫的重鬱症傾向者,使用抗憂鬱藥物治療憂鬱症的機會較低。對衛生政策及心理精神醫療服務提供者來說,如何降低老人的心理精神醫療就醫障礙,是制定老人憂鬱照護政策的重點,特別是居住在鄉村、居家無照顧者和需要部分負擔的重鬱症傾向者,而我們可利用社區式長期照護模式、部分負擔減免、照顧者的職能訓練、民眾衛教、醫事人員教育等方式,來提高大眾對於失能老人憂鬱症的辨識、診斷及治療率。 | zh_TW |
dc.description.abstract | The objectives of this study were to understand the distribution of severe depressive symptoms, and antidepressant utilization among disabled elderly in Taiwan. To explore factors associated with antidepressant use in severe depressive elderly.
Data were used from the ‘Evaluation of Taiwan National Requirements for Long-Term Care’, and 12,030 disabled people aged 65 years and above were enrolled in the current study. The Center for Epidemiological Studies Depression scale was used to define two groups: non-depressed (CES-D<25) and severe depressive symptoms (CES-D≧25). Subject identification information was linked to the National Health Insurance claim database to obtain antidepressant prescription data and diagnosis, including ambulatory visits and inpatient care, from the month of interview to one year later. The prevalence rate of antidepressant utilization in the full sample (N=12,030) and the antidepressant treatment rate in the severe depressive sample were both measured. And the associations of antidepressant use with demographic, heath and care, social network and social support factors among severe depressive sample were analyzed. The results indicated that the average CES-D score of the full sample was 13.3, and 1,015 respodents (12.6%) had severe depressive symptoms. In bivariate analyses, women, 65-74 years (young old), less education, don’t requiring co-payment, living in a municipality, cognitive impairment, physically dependent, more than four chronic conditions, living in institutions, low social network, low emotional support, and low instrumental support were associated with severe depressive symptoms. The annual prevalence rate of antidepressant utilization among full sample was 12.5% (TCAs of 39.0%, Heterocyclics of 27.3%, SSRIs of 21.8%, and MAOIs of 11.9%), and the number of annual antidepressant prescriptions was 10,276. Only 3,244 (31.6%) antidepressant prescriptions were used for depression (SSRIs of 42.8%, Hetrocyclics of 29.8%, TCAs of 16.8%, MAOIs of 10.6%). Average number of antidepressant prescriptions among antidepressant users was 6.9 annually. The annual antidepressant treatment rate of severe depressive sample was 17.5%. Only 60 (5.9%) severe depressive people use antidepressant for depression. In bivariate analysis, drug category was significantly associated with diagnosis. SSRIs (62.0%) was used mostly for depression, but TCAs (74.1%), MAOIs (61.2%), and Heterocyclics (40.0%) were usedly mostly for other diseases. Different specialists’ prescription patterns were not the same. Psychiatrists prescribed SSRIs most, rehabilitation department prescribed Heterocyclics most. Others like neurologist, internist, family medicine, urologist, orthopedics, and dermatologist prescribed TCAs most. In a multiple logistic regression model, age, co-payment, care arrangement, tendency to usual healthcare sources significantly associated with antidepressant treatment of severe depressive people. Compared to 85 years and above, 65-74 years (OR=2.342, 95%CI=1.173-4.674) and 75-84 years (OR=2.113, 95%CI=1.089-4.099) severe depressive people were more likely to use antidepressants. Compared to those requiring co-payment, those don’t requiring co-payment (OR=1.636, 95%CI=1.090-2.456) were more likely to use antidepressants. Compared to those with no caregivers, those with family caregivers (OR=1.482, 95%CI=0.876-2.506), and with a full-time personal aide (OR=2.572, 95%CI=1.260-5.248) were more likely to use antidepressants. Compared to those with high tendency to usual healthcare resources, those with low tendency (OR=3.696, 95%CI=2.191-6.236), and with intermediate tendency (OR=1.555, 95%CI=0.844-2.863) were more likely to use antidepressants. In a multiple logistic regression model, co-payment, residential area, care arrangement, and tendency to usual healthcare sources significantly associated with antidepressant treatment for depression among severe depressive people. Compared to those requiring co-payment, those don’t requiring co-payment (OR=2.211, 95%CI=1.167-4.189) were more likely to use antidepressants for depression. Compared to those living in a town, those living in a municipality (OR=3.276, 95%CI=1.443-7.435), in a provincial city (OR=1.496, 95%CI=0.640-3.500), and in a county-controlled city (OR=1.178, 95%CI=0.491-2.823) were more likely to use antidepressants for depression. Compared to those with no caregivers, those with family caregivers (OR=1.175, 95%CI=0.496-2.782), and with a full-time personal aide (OR=3.250, 95%CI=1.102-9.583) were more likely to use antidepressants for depression. Compared to those with high tendency to usual healthcare resources, those with low tendency (OR=3.069, 95%CI=1.276-7.383), and with intermediate tendency (OR=1.189, 95%CI=0.404-3.498) were more likely to use antidepressants for depression. In summary, depression in disabled elderly was a quite common problem, but the antidepressant treatment rate among severe depressive people was very low. Those who lived in a small town, with no caregivers, requiring co-payment, or with low tendency to usual healthcare resources had the lowest opportunity to receive antidepressant treatment for depression. How to minimize the barrier to mental health services, especially for those living in small towns, with no caregivers, or those requiring co-payment, was the most important goal for health policy makers and mental health services providers to make elderly depression care policy. We could improve the recognition, diagnosis and the treatment rate of depression through development of community-based long-term care system, reducing co-payment, training the caregivers, provide health education lessons to the public, or further professional knowledge about elderly depression to the health providers. | en |
dc.description.provenance | Made available in DSpace on 2021-05-20T20:28:54Z (GMT). No. of bitstreams: 1 ntu-97-R95845104-1.pdf: 777378 bytes, checksum: 091ca89269be2d7d1624a7c3e4a132f1 (MD5) Previous issue date: 2008 | en |
dc.description.tableofcontents | 誌謝……………………………………………………………………………………………………………………………..i
中文摘要………………………………………………………………………………………………………………..…..ii 英文摘要………………………………………………………………………………………………………………..…..v 目錄………………………………………………………………………………………………………………………….viii 表目錄…………………………………………………………………………………………………………………..……ix 圖目錄…………………………………………………………………………………………………………………..…….x 附錄……………………………………………………………………………………………………………………..……..x 第一章 前言……………………………………………………………………………………………………..………1 第一節 研究背景……………………………………………………………………………………..……….1 第二節 研究目的……………………………………………………………………………………..……….8 第三節 研究重要性…………………………………………………………………………………….……9 第二章 文獻探討…………………………………………………………………………………………..……….10 第一節 憂鬱…………………………………………………………………………………………..……….10 第二節 憂鬱症的藥物治療………………………………………………………………………….…21 第三節 各國抗憂鬱藥物使用情形…………………………………………………………………28 第四節 抗憂鬱藥物使用相關因素…………………………………………………………………49 第三章 研究方法……………………………………………………………………………………………………61 第一節 研究架構與假說………………………………………………………………………………..61 第二節 研究材料……………………………………………………………………………………….…..63 第三節 研究變項及操作型定義……………………………………………………………….……65 第四節 資料處理及分析方法………………………………………………………………………..72 第四章 研究結果……………………………………………………………………………………………………73 第一節 樣本特質…………………………………………………………………………………………...73 第二節 重鬱症傾向分佈情形………………………………………………………………..…..….76 第三節 抗憂鬱藥物使用情形……………………………………………………………………..…79 第四節 有重鬱症傾向者是否用藥的雙變項及多變項分析……………………..…..86 第五章 結論與討論…………………………………………………………………………………………..…..94 第一節 研究結果重點及討論…………………………………………………………………..……94 第二節 研究限制……………………………………………………………………………………..…..109 第三節 政策意涵………………………………………………………………………………………….111 第四節 未來研究建議……………………………………………………………………………..…..115 參考文獻…………………………………………………………………………………………………………………140 表目錄 表2-1 CES-D問卷的效度…………………………………………………………………………………………15 表2-2各國老人憂鬱症狀盛行率比較………………………………………………………………………20 表2-3各國抗憂鬱藥物使用盛行率…………………………………………………..……………………..35 表2-4憂鬱者的抗憂鬱藥物治療率…………………………………………………………………………..43 表2-5抗憂鬱藥物適應症………………………………………………………………………………………….47 表2-6 抗憂鬱藥物使用相關因素比較……………………………………………………………………..58 表4-1基本特質分佈:人口學背景…………………………………………………………………………..117 表4-2基本特質分佈:健康與照顧狀況…………………………………………………………………118 表4-3失能老人憂鬱分數………………………………………………………………………………………..119 表4-4失能老人重鬱症傾向分佈情形:人口學特質……………………………………………….120 表4-5失能老人重鬱症傾向分佈情形:健康與照顧狀況………………………………………121 表4-6失能老人重鬱症傾向分佈情形:社會支持系統……………………………………………122 表4-7抗憂鬱藥物使用情形:年使用盛行率與每人年平均處方數……………………….123 表4-8-1抗憂鬱藥物使用情形:處方藥品及類別比率…………………………………………….123 表4-8-2抗憂鬱藥物使用情形:處方藥品及類別比率(用於治療憂鬱症的處方) ….124 表4-9 藥物類別和疾病診斷的雙變項分析……………………………………………………………124 表4-10-1抗憂鬱藥物使用情形:處方科別及疾病診斷比率………………………………….125 表4-10-2抗憂鬱藥物使用情形:處方科別(用於治療憂鬱症) ……………………………….126 表4-11-1抗憂鬱藥物使用分析:處方科別與藥物類別…………………………………………127 表4-11-2抗憂鬱藥物使用分析:處方科別與藥物類別(用於治療憂鬱症) …………128 表4-12-1 CES-D樣本是否使用抗憂鬱藥物的分佈情形(不同CES-D切點) …………129 表4-12-2 CES-D樣本是否使用抗憂鬱藥物治療憂鬱症的分佈情形(不同CES-D切點) …………………………………………………………………………………………………………………………..129 表4-12-3 CES-D樣本是否被診斷為憂鬱症的分佈情形(不同CES-D切點) …………129 表4-13重鬱症傾向者是否用藥的雙變項分析:人口學背景………………………………….130 表4-14重鬱症傾向者是否用藥的雙變項分析:健康與照顧狀況………………………….131 表4-15重鬱症傾向者是否用藥的雙變項分析:社會支持系統……………………………..132 表4-16重鬱症傾向者是否用藥治療憂鬱症的雙變項分析:人口學背景……………..133 表4-17重鬱症傾向者是否用藥治療憂鬱症的雙變項分析:健康與照顧狀況……..134 表4-18重鬱症傾向者是否用藥治療憂鬱症的雙變項分析:社會支持系統…………..135 表4-19重鬱症傾向者是否用藥的多變項分析……………………………………………………….136 表4-20重鬱症傾向者是否用藥治療憂鬱症的多變項分析……………………………………138 表4-21 重鬱症傾向者用藥及用藥治療憂鬱症的多變項分析結果比較……………….139 圖目錄 圖3-1研究架構…………………………………………………………………………………………………………62 附錄 附錄一、CES-D問卷遺漏值處理…………………………………………………………………………….155 附錄二、疾病分類與ICD-9診斷碼………………………………………………………………………….157 附錄三、抗憂鬱藥物分類………………………………………………………………………………….…….157 | |
dc.language.iso | zh-TW | |
dc.title | 臺灣失能老人的抗憂鬱藥物使用研究 | zh_TW |
dc.title | Antidepressant Utilization Among Disabled Elderly in Taiwan | en |
dc.type | Thesis | |
dc.date.schoolyear | 96-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 黃文鴻,張玨 | |
dc.subject.keyword | 失能老人,抗憂鬱藥物使用,重鬱症傾向,適應症,盛行率, | zh_TW |
dc.subject.keyword | disabled elderly,antidepressant use,severe depressive symptoms,indication,prevalence, | en |
dc.relation.page | 157 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2008-08-01 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 衛生政策與管理研究所 | zh_TW |
顯示於系所單位: | 健康政策與管理研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-97-1.pdf | 759.16 kB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。